Difficulty: Medium
Average Score: 95%
Practice
A 13-year-old female presents with 3 months of easy bruisability and bone pain. Complete blood count shows extreme leukocytosis. She is diagnosed with ALL and begins a chemotherapy regimen. One of her chemotherapeutic drugs is cyclophosphamide. What should also be given to avoid a potentially serious side effect of cyclophosphamide?
Correct answer
A
Rationale
In this scenario, the correct answer is A) Mesna. Mesna is a uroprotective agent commonly used with cyclophosphamide to prevent hemorrhagic cystitis, a potentially serious side effect of the chemotherapy drug. Cyclophosphamide can cause bladder toxicity, leading to inflammation and hemorrhage in the bladder mucosa. Mesna works by binding to acrolein, a toxic metabolite of cyclophosphamide, and reducing its harmful effects on the bladder lining.
Option B) Methylene blue is not indicated in this case as it is used as an antidote for methemoglobinemia, not for preventing cyclophosphamide-induced hemorrhagic cystitis.
Option C) N-acetylcysteine is mainly used for acetaminophen overdose to prevent liver toxicity and is not relevant in preventing cyclophosphamide-induced bladder toxicity.
Option D) Ibuprofen is a non-steroidal anti-inflammatory drug that does not provide protection against cyclophosphamide-induced bladder toxicity.
From an educational perspective, understanding the rationale behind the use of Mesna with cyclophosphamide highlights the importance of supportive care in managing chemotherapy side effects. Healthcare providers need to be aware of the appropriate supportive medications to mitigate potential toxicities associated with chemotherapy drugs to ensure the best outcomes for pediatric patients undergoing cancer treatment.
Option B) Methylene blue is not indicated in this case as it is used as an antidote for methemoglobinemia, not for preventing cyclophosphamide-induced hemorrhagic cystitis.
Option C) N-acetylcysteine is mainly used for acetaminophen overdose to prevent liver toxicity and is not relevant in preventing cyclophosphamide-induced bladder toxicity.
Option D) Ibuprofen is a non-steroidal anti-inflammatory drug that does not provide protection against cyclophosphamide-induced bladder toxicity.
From an educational perspective, understanding the rationale behind the use of Mesna with cyclophosphamide highlights the importance of supportive care in managing chemotherapy side effects. Healthcare providers need to be aware of the appropriate supportive medications to mitigate potential toxicities associated with chemotherapy drugs to ensure the best outcomes for pediatric patients undergoing cancer treatment.